RGEN

#3722
Repligen Corporation - Common Stock
1.2 4 USD
-98.99%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
1.24
1.24
Range Annuel
1.12
175.57
Changement quotidien
-98.99%
Changement Mensuel
-98.91%
Evolution sur 6 mois
-99.26%
Changement Annuel
-99.25%
Clôture Précédente
122.7 3
Open
1.2 4
Low
1.2 4
High
1.2 4
Volume
154
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur 202020212022202320242025 TTM

Repligen Corporation - Common Stock

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. The company is based in Waltham, Massachusetts, and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biopharmaceutical drug developers and contract development and manufacturing organizations worldwide.

Nouvelles